China Dermal Fillers Market: By Product Type (Absorbable Dermal Fillers, Non-Absorbable Dermal Fillers),  By ingredient (Hyaluronic Acid (HLA), Poly-L-Lactic Acid (PLA), Calcium Hydroxylapatite (CaH), Polymethylmethacrylate (PMMA), Collagen, Others), By Distribution Channel (Retail Pharmacies, Beauty Clinics, Others)  

Purchase Option

$ 3100
$ 4600
$ 6900

China Dermal Fillers Market size was valued at USD x billion in 2021 and is expected to reach USD x billion by 2028, at a CAGR of x% during the forecast period 2022 to 2028. Dermal filling is a non-invasive procedure which helps in the rejuvenation of the skin. China is one of the largest hub for the cosmetic surgery. The pursuit of physical beauty has become a big business in China. According to the China Association of Plastics and Aesthetics (CAPA), in the year of 2014, China’s cosmetic surgery industry has valued at 400 billion yuan with more than 7 million people having cosmetic surgery. The dermal filler market is gaining popularity all over the globe.  

China Dermal Fillers Market Key Developments:
In September 2016, Suneva Medical, Inc., announced that Bellafill is the only FDA approved dermal filler with demonstrated safety and effectiveness through five years, following the completion of its five year post-approval study for nasolabial folds.

China Dermal Fillers Market Dynamics

Increase in the interest in the hyaluronic acid filler treatment is majorly driving the dermal filler market in China. The effective treatment procedures are drawing attention of the people which is likely to enhance the market. The life styles changes and the growing beauty consciousness is enriching the growth of the China dermal fillers market. The tremendous popularity of the cosmetic products is bringing awareness among the people and powerful social media platforms are aiding the China dermal fillers market growth.

China Dermal Fillers Market Segmentation

By Product Type
  • Absorbable Dermal Fillers,
  • Non-Absorbable Dermal Fillers
By ingredient
  • Hyaluronic Acid (HLA)
  • Poly-L-Lactic Acid (PLA)
  • Calcium Hydroxylapatite (CaH)
  • Polymethylmethacrylate (PMMA)
  • Collagen
  • Others
Distribution Channel
  • Retail Pharmacies
  • Beauty Clinics
  • Others

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
  • Galderma
  • Allergan
  • Merz
  • Sinclair
  • LG Life Sciences
  • Bloomage Bio Technology,
  • SciVision Biotech
  • Suneva Medical

Adjacent Markets